Vitamin D Homeostasis in Sarcoidosis
Sponsor: University of Texas Southwestern Medical Center • ClinicalTrials.gov ID: NCT03621553
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This study evaluates the relationship between vitamin-D status and severity of sarcoidosis, and the effects of vitamin-D repletion in vitamin-D insufficient patients with sarcoidosis. Half the patients with sarcoidosis who are vitamin-D insufficient will receive standard vitamin-D supplementation via standard regimen while the other half will receive a placebo. Sarcoidosis patients who are vitamin-D sufficient will also act as controls.
Interventions
-
Ergocalciferol
(Drug)
Vitamin D2 50,000 units
-
Placebo
(Drug)
Sugar pill manufactured to mimic ergocalciferol 50,000 units
-
Calcium Citrate with Vitamin D2
(Drug)
To meet the recommended minimum daily dietary requirements
Eligibility criteria
Conditions
Locations
- University of Texas Southwestern Medical Center, and Parkland Health and Hospital System — Dallas, Texas, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record